College of Life and Environmental Science, Wenzhou University, Wenzhou, Zhejiang, China.
Natural Drug Discovery Group, School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
PLoS One. 2020 Dec 3;15(12):e0243326. doi: 10.1371/journal.pone.0243326. eCollection 2020.
Bradykinin-related peptides (BRPs) family is one of the most significant myotropic peptide families derived from frog skin secretions. Here, a novel BRP callitide was isolated and identified from the red-eyed leaf frog, Agalychnis callidryas, with atypical primary structure FRPAILVRPK-NH2. The mature peptide was cleaved N-terminally at a classic propeptide convertase cleavage site (-KR-) and at the C-terminus an unusual -GKGKGK sequence was removed using the first G residue as an amide donor for the C-terminally-located K residue. Thereafter, the synthetic replicates of callitide were assessed the myotropic activity and showed a significant contraction of balder, with the 0.63 nM EC50 value, more potent than most discovered myotropic peptides. The binding mode was further speculated by molecular docking and stimulation. The result indicated that the C-terminal of callitide might selectively bind to bradykinin receptor B2 (BKRB2). Further investigation of the callitide needs to be done in the future to be exploited as potential future drug leads.
缓激肽相关肽(BRPs)家族是从蛙皮分泌物中衍生出来的最重要的肌活性肽家族之一。在这里,从红眼叶蛙(Agalychnis callidryas)中分离并鉴定了一种新型的 BRP 肽,称为 callitide,其具有非典型的初级结构 FRPAILVRPK-NH2。成熟肽在经典的前肽转化酶切割位点(-KR-)处从 N 端切割,并在 C 端去除不寻常的 -GKGKGK 序列,第一个 G 残基作为酰胺供体用于 C 端定位的 K 残基。此后,对 callitide 的合成复制品进行了肌活性评估,结果显示其对头皮的收缩作用显著,EC50 值为 0.63 nM,比大多数已发现的肌活性肽更有效。进一步通过分子对接和刺激来推测结合模式。结果表明,callitide 的 C 端可能选择性地与缓激肽受体 B2(BKRB2)结合。未来需要进一步研究 callitide,以开发为潜在的未来药物先导物。